NCT06150807

Brief Summary

The aim of this study is to identify incidence of portal vein thrombosis after umbilical catheter and to identify the risk factor of this condition ,location of PVT and prognosis of PVT.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
45

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Dec 2023

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 21, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

November 29, 2023

Completed
21 days until next milestone

Study Start

First participant enrolled

December 20, 2023

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 30, 2025

Completed
Last Updated

December 6, 2023

Status Verified

November 1, 2023

Enrollment Period

1 year

First QC Date

November 21, 2023

Last Update Submit

November 30, 2023

Conditions

Portal Vein Thrombosis

Outcome Measures

Primary Outcomes (1)

  • Frequency and risk factors of portal vein thrombosis in neonate with umbilical catheter

    Identify incidence of portal vein thrombosis after umbilical catheter,Identify the risk factor of this condition ,location of PVT and prognosis of PVT.

    baseline

Interventions

ultrasound and dopplerDEVICE

Ultrasound examinations of the liver and spleen including color Doppler imaging of the portal veins, hepatic veins, splenic vein, and superior mesenteric vein will done in the Department of Pediatric

Eligibility Criteria

Age1 Day - 28 Days
Sexall
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

all neonates with UVC, who will admitted to the Neonatal intensive care Unit Assiut University Children's Hospital had undergo UVC for any cause between 10/2023 to 9/2024 limited to diagnosis established in neonates \<28-day chronological age.

You may qualify if:

  • the study population: all neonates with UVC, who will admitted to the Neonatal intensive care Unit Assiut University Children's Hospital had undergo UVC for any cause between 10/2023 to 9/2024 limited to diagnosis established in neonates \<28-day chronological age.

You may not qualify if:

  • Neonate who has PVT but not had UVC before .

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Salimi M. Comparison of beta-adrenoceptor blocking properties of sotalol, oxprenolol, propranolol and pindolol on rabbit intestinal smooth muscle. Pharmacology. 1975;13(5):441-7. doi: 10.1159/000136936.

    PMID: 1802BACKGROUND

MeSH Terms

Interventions

Ultrasonography, Doppler

Intervention Hierarchy (Ancestors)

UltrasonographyDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosis

Central Study Contacts

esraa mostafa

CONTACT

01092686005Esraa25197@gmail.com

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MA Researcher

Study Record Dates

First Submitted

November 21, 2023

First Posted

November 29, 2023

Study Start

December 20, 2023

Primary Completion

December 30, 2024

Study Completion

January 30, 2025

Last Updated

December 6, 2023

Record last verified: 2023-11